Glucotrack, Inc. — Form 10-Q
Filed August 14, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
This is a routine quarterly report (10-Q) for Glucotrack, Inc. covering the period ended June 30, 2026, filed August 14, 2026. The filing document index shows standard SEC exhibits (SOX certifications, XBRL data files) but the actual financial statements, MD&A, and business narrative are not included in the excerpt provided. No specific dollar amounts, transactions, counterparties, or material events are disclosed in the text supplied.
Why this rating
Routine quarterly filing with no disclosed material transactions. Absence of detailed results prevents assessment of operational changes relative to $5.4M market cap.
See more from August 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.